This presentation looks at WHO including issue facing WHO.

1. WHO – World Health
Organization
PAUL YOUNG CPA CGA
APRIL 1, 2020

2. Paul Young - Bio
• CPA, CGA
• Academia (PF1, FA4 and MS2)
• SME – Risk Management
• SME – Close, Consolidate and Reporting
• SME – Public Policy
• SME – Emerging Technology
• SME – Financial Solutions
• SME – Business Process Change
• SME – Supply Chain Management
Contact information:
Paul_Young_CGA@Hotmail.com

3. Agenda
 WHO – Mandate
 WHO – Membership / Board
 Member countries
 WHO Funding
 Oversight
 Other Training/Development
 How to transform the WHO

4. WHO – Mandate
Source - https://www.who.int/about

5. Board Members
Source - https://apps.who.int/gb/gov/en/composition-of-the-board_en.html
Best Healthcare System Ranking

6. Member Countries
Source - https://www.who.int/countries/en/
No Taiwan
WHO praises China, but refuses to discuss
Taiwan
https://www.who.int/bulletin/volumes/85/07-
100107/en/index1.html

7. Funding/WHO
Source - https://www.who.int/about/finances-accountability/reports/en/

8. Oversight and Performance Audits
Source – WHO
• Internal audits in the past have show
issues with effectiveness of programs
and/or oversight
• All donors should be asking for more
performance audits as part of
assessing the effectiveness of WHO
programs
• An annual audited risk management
report should be provided including
assessing global risk, crisis
management, etc.
• More work needs to be done in terms
of using data sciences and analytics as
part of managing various programs
with WHO

9. Training and Development
 If you like to learn more
about trade and/or other
subjects as part of your
professional learning and
development then feel free
to review my material on
https://www.udemy.com/
(search Paul Young CPA
CGA)
 These subjects address
how to fixed issues with
housing and/or systemic
issues related to economy
including government
policies

10. What’s should be next for WHO
 More oversight into programs including performance audits
 More accountability and transparency when it comes to management of
programs including crisis management.
 More oversight into risk management including risk management reporting
(mitigation of risks)
 Adjusting the board to include both donors and country representation
 i.e. pharma, technology, health experts, etc.